DNAI2 Gene Primary Ciliary Dyskinesia Type 9 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Respiratory Health
The DNAI2 Gene Primary Ciliary Dyskinesia Type 9 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for respiratory disorders. This advanced next-generation sequencing test specifically targets mutations in the DNAI2 gene, which plays a critical role in the structure and function of cilia – the microscopic hair-like structures lining our respiratory tract. When these cilia malfunction due to genetic mutations, it leads to Primary Ciliary Dyskinesia Type 9, a rare inherited condition affecting multiple body systems.
What This Test Measures and Detects
Our comprehensive NGS genetic test analyzes the complete DNAI2 gene sequence to identify:
- Point mutations and single nucleotide variants
- Insertions and deletions affecting gene function
- Copy number variations and structural changes
- Pathogenic variants known to cause PCD Type 9
- Novel mutations with potential clinical significance
Who Should Consider This Genetic Test
This test is particularly recommended for individuals experiencing:
- Chronic respiratory symptoms beginning in infancy or childhood
- Recurrent sinus infections and persistent nasal congestion
- Frequent pneumonia or bronchitis episodes
- Chronic cough with excessive mucus production
- Middle ear infections and hearing problems
- Fertility issues in males due to sperm motility problems
- Family history of Primary Ciliary Dyskinesia
- Situs inversus (organs on opposite sides of the body)
Significant Benefits of Genetic Testing
Undergoing the DNAI2 gene test provides numerous advantages:
- Accurate Diagnosis: Confirms or rules out Primary Ciliary Dyskinesia Type 9
- Personalized Treatment: Guides targeted therapeutic approaches
- Family Planning: Provides crucial information for genetic counseling
- Early Intervention: Enables proactive management of symptoms
- Comprehensive Care: Supports multidisciplinary treatment planning
- Peace of Mind: Reduces diagnostic uncertainty and anxiety
Understanding Your Test Results
Our genetic counselors provide comprehensive interpretation of your results:
- Positive Result: Indicates presence of pathogenic DNAI2 mutations confirming PCD Type 9 diagnosis
- Negative Result: Suggests absence of detectable mutations in the DNAI2 gene
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Identifies individuals who may pass the condition to offspring
Test Details and Pricing
| Test Parameter | Details |
|---|---|
| Test Name | DNAI2 Gene Primary Ciliary Dyskinesia Type 9 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
| Specialty | ENT Doctor, Genetics Department |
Pre-Test Preparation and Requirements
Before undergoing testing, we recommend:
- Comprehensive clinical history documentation
- Genetic counseling session to discuss implications
- Family pedigree analysis for inheritance patterns
- Discussion of potential outcomes and next steps
- Informed consent process completion
Nationwide Testing Availability
We have conveniently located testing centers across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.
Take Control of Your Respiratory Health Today
Don’t let uncertainty about your respiratory symptoms continue. Our DNAI2 Gene Primary Ciliary Dyskinesia Type 9 NGS Genetic DNA Test provides the clarity you need for proper diagnosis and treatment planning. With our discounted price of $500 USD (regularly $700 USD), advanced genetic testing is more accessible than ever.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward understanding your genetic health.
